CBD is released by Anvisa and may be produced in Brazil

 



By Camila Almeida Cannabidiol (CBD), present in marijuana, has been removed from the list of prohibited drugs and has been included in the list of controlled substances in Brazil. The National Health Surveillance Agency (Anvisa) decided to reclassify the substance on Wednesday (14), at a meeting of the board, unanimously. The measure allows doctors to prescribe

Cannabidiol (CBD), present in marijuana, has been removed from the list of prohibited drugs and has been included in the list of controlled substances in Brazil. The National Health Surveillance Agency (Anvisa) decided to reclassify the substance on Wednesday (14), at a meeting of the board, unanimously. The measure allows physicians to prescribe the substance to their patients, de-bureaucrates the import process and the entry of the product into the country, facilitates researchers' access to the CBD and legalizes the production and commercialization of medicines by Brazilian or foreign laboratories.
In December, the Federal Medical Council had released , by way of exception, and only in the last case, that physicians could prescribe the substance, even if it is prohibited, to patients under 18 years of age with epilepsy or drug-resistant seizures Available and in limited doses. Otherwise, they continued to run the risk of having the professional registration revoked. With the release of Anvisa, adult patients with other diseases may also benefit, and physicians should be given more freedom in prescription.
Another advantage is the possibility that drugs will soon be marketed in Brazil, which would considerably reduce the cost of CBD and the time it takes to reach families. In a note, Anvisa reported that a foreign laboratory has already made the request to sell the Wholesale CBD Isolate here and the proposed composition is under analysis. The next step is to carry out an inspection at the factory to verify that the company meets all the requirements. Currently, the American laboratory that exports ampoules to Brazilians charges US $ 450 for every 10g of the substance's oil, excluding import taxes. There are 336 patients importing these ampoules, but they are inaccessible to low-income families.
Although it is said that the CBD has left the list of prohibited substances, the truth is that it has never been there. Who is (and continues to be) on the banned Anvisa list is Cannabis sativa (scientific name for marijuana). Tetrahydrocannabinol (THC) and its variations, because they have psychoactive effect, also continue to appear among the condemned, despite their medicinal effects also proven in research.
In February last year, a special edition of SUPER titled The Marijuana Revolution hit the stands. The story of the Fischer family, who decided to circumvent the law and import the CBD to control 80 weekly seizures of Anny, a little girl of only 5 years at the time, showed all the difficulty (and illegality) of medicating in Brazil, also faced by other patients . It was a struggle that these people did not need to be considered traffickers or take legal risks to get treated.
Katiele, Anny's mother, became a symbolic character of this battle, for the courage and the potential of mobilization that managed its history managed to generate. "Do you believe that tomorrow, January 15, exactly one year ago I received the first call from Tarso [Araรบjo, journalist who edited the SUPER special]? And I was so happy that someone was finally listening to me, telling me what people were going through. And scared to death that he was a police officer, "laughs Katiele, on the phone, celebrating Anvisa's decision. "We are extremely pleased with this step, which will allow us to discuss medical marijuana more consistently from now on," celebrates Norny, Anny's father.
In February, a short film designed and developed by Tarso, Raphael Erichsen and Rodrigo Braga, spread the story across the country and made medical marijuana gain prominence in the press. In October, the film Illegal in theaters was released , telling the story of several mothers and patients who needed medical marijuana to medicate themselves and the fight with Anvisa. It was SUPER's debut in theaters. And along with our name on the screen was the feeling of being involved and contributing to the construction of something larger than a magazine or documentary. Feeling that was confirmed today, at Anvisa.

No comments:
Write comments